Sino Biopharmaceutical Ltd 2020 SR
The report highlights Sino Biopharmaceutical's commitment to R&D and innovation, with a total R&D expenditure of RMB 2.85 billion in 2020. The company achieved national Green Factory status for its subsidiary CT Tianqing and implemented various energy-saving measures, including a grid-connected photovoltaic power station. It details social contributions, specifically donating RMB 22 million in funds and supplies to combat the COVID-19 pandemic. The Group also focuses on employee development, health, and safety, reporting zero work-related fatalities for the year.
Company: Sino Biopharmaceutical Ltd
Sector: Manufacturing
Country: Hong Kong
Year: 2020
Type: SR
Pages: 38
Back to company
Sino Biopharmaceutical Ltd
ESG Report
The report highlights Sino Biopharmaceutical's commitment to R&D and innovation, with a total R&D expenditure of RMB 2.85 billion in 2020. The company achieved national Green Factory status for its subsidiary CT Tianqing and implemented various energy-saving measures, including a grid-connected photovoltaic power station. It details social contributions, specifically donating RMB 22 million in funds and supplies to combat the COVID-19 pandemic. The Group also focuses on employee development, health, and safety, reporting zero work-related fatalities for the year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Workplace Fatalities
Employees